Advertisement

Topics

Shire's long-acting ADHD drug wins U.S. approval

20:24 EDT 20 Jun 2017 | Reuters

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Shire Plc's long-acting therapy for attention deficit hyperactivity disorder (ADHD), adding another treatment to its stock of drugs for the cognitive condition that affects m...

Original Article: Shire's long-acting ADHD drug wins U.S. approval

NEXT ARTICLE

More From BioPortfolio on "Shire's long-acting ADHD drug wins U.S. approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...